日本語
TOP page
Published papers
Academic conference presentation
(Last updated : 2022-05-26 17:06:04)
武田 志帆
Department
School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Nephrology
Position
Assistant Professor
■
Published papers
1.
Original article
Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polystic Kidney Disease 2022/05/20
2.
Original article
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease 2022/01/29
3.
Original article
Germline Mutations for Kidney Volume in ADPKD 2021/12/13
4.
Original article
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD 2021/07/14
5.
Original article
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease 2021/07
6.
Original article
Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease 2021/04/02
7.
Original article
Impact of visceral fat area in patients with chronic kidney desease 2021/02/17
8.
Original article
Sex Differences in Time-Series Changes in Pseudo-R² Values Regarding Hyperuricemia in Relation to the Kidney Prognosis 2020/11/26
9.
Original article
Visceral to subcutaneous fat ratio as an indicator of a ≧30% eGFR decline in chronic kidney disease 2020/11
10.
Original article
Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes 2020/08
11.
Original article
Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease. 2020/04
12.
Original article
High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study 2020/03/10
13.
Original article
Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. 2020/02/08
14.
Original article
Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations. 2020/01/05
15.
Original article
Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance(MGRS) 2019/10/17
16.
Original article
Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome 2019/08/20
17.
Original article
Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients 2019/04
18.
Original article
PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion 2019/01
19.
Original article
Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis:A case report. 2019/01
20.
Original article
Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/12
21.
Original article
Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to retuximab therapy between childhood-onset and adult-onset disease. 2018/10
22.
Original article
Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD). 2018/10
23.
Original article
Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Repuired Surgical Treatment 2018/08
24.
Original article
A case of unilateral nephrectomy performed for autosomal dominant polycystic kidney disease with marked unilateral enlargement. 2018/05
25.
Original article
New Insights into Cystic Kidney Diseases. 2018/05
26.
Original article
Successful treatment with steroid and cyclosporine A in a patient with immunoglobulin A-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. 2018/03
Display 5 items
Display all(26)
■
Academic conference presentation
1.
Relationship of tolvaptan dose with the rate of decline in kidney function in ADPKD patients. 2019/11/07
2.
Elevation of the liver enzyme levels during tolvaptan treatment with autosomal dominant polycystic kidney disease (ADPKD) 2018/02/22